Synthesis, characterization, molecular modeling studies, and biological evaluation of metal piroxicam complexes (M = Ni(II), Pt(IV), Pd(II), Ag(I)) as antibacterial and anticancer agents

• Published in: Drug development research 2024-04, Vol.85 (2), p.e22156-n/a
• Main Authors: Soliman, Aya M., El‐sagheir, Ahmed M. K., Thabet, Momen M., Abdel Hakiem, Ahmed Faried, Aboraia, Ahmed S.
• Format: Article
• Language: English
• Subjects: Anti-Bacterial Agents - pharmacology; Antibacterial activity; Anticancer properties; Antimicrobial activity; Antineoplastic Agents - pharmacology; Antineoplastic drugs; Antitumor activity; bacterial infection; Cancer; Chemical synthesis; Colon cancer; Coordination Complexes - pharmacology; Coordination compounds; Cytotoxicity; Deoxyribonucleic acid; DNA; DNA Gyrase; DNA topoisomerase; E coli; Electrostatic properties; Hepatocytes; Humans; Liver cancer; Metal complexes; Microbial Sensitivity Tests; Minimum inhibitory concentration; Modelling; Molecular Docking Simulation; molecular modeling; Molecular modelling; Nickel; Palladium; Piroxicam; Piroxicam - pharmacology; Platinum; repurposing; Silver
• ISSN: 0272-4391; 1098-2299
• DOI: 10.1002/ddr.22156

Four piroxicam metal complexes; NiL2, PtL2, PdL2, and AgL were synthesized and characterized by different techniques with enhanced antibacterial and anticancer activity. Regarding in vitro antimicrobial activity, complex NiL2 displayed potent antibacterial effect against Escherichia coli and Pseudomonas aeruginosa that was 1.9‐folds higher than piroxicam (minimum inhibitory concentration [MIC] = 31.85, 65.32 µM), respectively. In case of G+ve bacteria, complex PtL2 had potent activity on Staphylococcus aureus which was 2.1‐folds higher than piroxicam (MIC = 43.12 µM), while activity of complex AgL against Enterococcus faecalis was threefolds higher than piroxicam (MIC = 74.57 µM. Complexes PtL2 and PdL2 exhibited higher inhibition of DNA gyrase than piroxicam (IC50 = 6.21 µM) in the range of 1.9–1.7‐folds. The in vitro antiproliferative activity depicted that all investigated complexes showed better cytotoxic effect than piroxicam, specifically Pt and Pd complexes which had lower IC50 values than piroxicam on human liver cancer cell line HepG2 by 1.8 and 1.7‐folds, respectively. While Pd and Ag complexes showed 2 and 1.6‐folds better effect on human colon cancer cell line HT‐29 compared with piroxicam. Molecular modeling studies including docking on Stranded DNA Duplex (1juu) and DNA gyrase enzyme (1kzn) that gave good insight about interaction of complexes with target molecules, calculation of electrostatic potential map and global reactivity descriptors were performed.